| 1 |
34988938 | PI3K inhibition by BKM120 results in anti-proliferative effects on corticotroph tumor cells. | 2022 May |
2 |
| 2 |
35460881 | BKM120 alters the migration of doublecortin-positive cells in the dentate gyrus of mice. | 2022 May |
1 |
| 3 |
33664847 | Vitamin C sensitizes triple negative breast cancer to PI3K inhibition therapy. | 2021 |
1 |
| 4 |
34887852 | Dual Targeting by Inhibition of Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Attenuates the Neuroinflammatory Responses in Murine Hippocampal Cells and Seizures in C57BL/6 Mice. | 2021 |
1 |
| 5 |
29495002 | Synergistic Antitumor Effect of BKM120 with Prima-1Met Via Inhibiting PI3K/AKT/mTOR and CPSF4/hTERT Signaling and Reactivating Mutant P53. | 2018 |
2 |
| 6 |
30103709 | Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment. | 2018 Aug 13 |
2 |
| 7 |
27811010 | Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities. | 2017 Feb |
1 |
| 8 |
27623107 | PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma. | 2016 Sep 13 |
1 |
| 9 |
26674543 | The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia. | 2015 Dec 17 |
1 |
| 10 |
24799524 | Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib). | 2014 Jul 1 |
2 |
| 11 |
25004403 | Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma. | 2014 Jun 15 |
4 |
| 12 |
22469977 | Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model. | 2013 Feb 21 |
1 |
| 13 |
22037215 | Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia. | 2012 Jul 5 |
2 |